Imunon: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Imunon (NASDAQ:IMNN) reported Q3 earnings with an EPS of $-0.37, beating estimates by 43.94% against an expected $-0.66. However, revenue declined by $125 thousand compared to the same period last year. Despite beating last quarter's EPS estimates, the share price fell by 4.13% the following day.
November 14, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Imunon reported a significant earnings beat but experienced a decrease in revenue compared to last year. Historically, the stock dropped after a previous earnings beat.
Imunon's earnings beat could be seen as positive, but the decline in revenue and historical stock price drop following the last earnings beat suggest potential short-term negative impact on the stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100